%PDF-1.4
%
1 0 obj
<<
/PageMode /UseOutlines
/Outlines 2 0 R
/Metadata 3 0 R
/Pages 4 0 R
/PageLayout /SinglePage
/OpenAction 5 0 R
/Type /Catalog
/PageLabels 6 0 R
/OutputIntents [7 0 R]
>>
endobj
8 0 obj
<<
/CreationDate (D:20090513155905+05'30')
/Author (Paul Ellis; Peter Barrett-Lee; Lindsay Johnson; David Cameron; Andrew Wardley; Susan O'Reilly; Mark Verrill; Ian Smith; John Yarnold; Robert Coleman; Helena Earl; Peter Canney; Chris Twelves; Christopher Poole; David Bloomfield; Penelope Hopwood; Stephen Johnston; Mitchell Dowsett; John MS Bartlett; Ian Ellis; Clare Peckitt; Emma Hall; Judith M Bliss; for the TACT Trial Management Group; the TACT Trialists)
/Creator (Elsevier)
/Keywords ()
/Producer (Acrobat Distiller 6.0 for Windows)
/AuthoritativeDomain#5B1#5D (sciencedirect.com)
/AuthoritativeDomain#5B2#5D (elsevier.com)
/ModDate (D:20090514022314+05'30')
/Title (Sequential docetaxel as adjuvant chemotherapy for early breast cancer \(TACT\): an open-label, phase III, randomised controlled trial)
/Trapped /False
>>
endobj
2 0 obj
<<
/First 9 0 R
/Count 12
/Last 9 0 R
/Type /Outlines
>>
endobj
3 0 obj
<<
/Length 6405
/Subtype /XML
/Type /Metadata
>>
stream
application/pdf
doi:10.1016/S0140-6736(09)60740-6
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial
Paul Ellis; Peter Barrett-Lee; Lindsay Johnson; David Cameron; Andrew Wardley; Susan O'Reilly; Mark Verrill; Ian Smith; John Yarnold; Robert Coleman; Helena Earl; Peter Canney; Chris Twelves; Christopher Poole; David Bloomfield; Penelope Hopwood; Stephen Johnston; Mitchell Dowsett; John MS Bartlett; Ian Ellis; Clare Peckitt; Emma Hall; Judith M Bliss; for the TACT Trial Management Group; the TACT Trialists
Elsevier Ltd
journal
The Lancet
Copyright © 2009 Elsevier Ltd. All rights reserved.
0140-6736
373
9676
16 May 2009
2009-05-16
1681-1692
1681
1692
10.1016/S0140-6736(09)60740-6
http://dx.doi.org/10.1016/S0140-6736(09)60740-6
1
B
Elsevier
2009-05-13T15:59:05+05:30
2009-05-14T02:23:14+05:30
2009-05-14T02:23:14+05:30
True
Acrobat Distiller 6.0 for Windows
False
uuid:cf8c33f1-8545-418c-a4d5-3cd5a7c6ac29
uuid:b413548b-019f-49bb-823f-027bcd66d06c
sciencedirect.com
elsevier.com
endstream
endobj
4 0 obj
<<
/Count 13
/Type /Pages
/Kids [10 0 R 11 0 R]
>>
endobj
5 0 obj
<<
/D [12 0 R /FitH -32768]
/S /GoTo
>>
endobj
6 0 obj
<<
/Nums [0 13 0 R]
>>
endobj
7 0 obj
<<
/Info (sRGB IEC61966-2.1)
/S /GTS_PDFA1
/OutputConditionIdentifier (sRGB IEC61966-2.1)
/DestOutputProfile 14 0 R
/Type /OutputIntent
>>
endobj
9 0 obj
<<
/First 15 0 R
/Parent 2 0 R
/A 16 0 R
/Count 11
/Last 17 0 R
/Title (Sequential docetaxel as adjuvant chemotherapy for early breast cancer \(TACT\): an open-label, phase III, randomised controlled trial)
>>
endobj
10 0 obj
<<
/Parent 4 0 R
/Count 11
/Type /Pages
/Kids [18 0 R 12 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R
27 0 R]
>>
endobj
11 0 obj
<<
/Parent 4 0 R
/Count 2
/Type /Pages
/Kids [28 0 R 29 0 R]
>>
endobj
12 0 obj
<<
/CropBox [0 0 612 792]
/Parent 10 0 R
/Contents [30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R]
/Rotate 0
/MediaBox [0 0 612 792]
/Thumb 38 0 R
/Resources <<
/XObject <<
/Im0 39 0 R
>>
/ColorSpace <<
/CS0 [/ICCBased 40 0 R]
>>
/Font <<
/T1_0 41 0 R
/T1_1 42 0 R
/T1_2 43 0 R
/T1_3 44 0 R
/T1_4 45 0 R
/T1_5 46 0 R
/T1_6 47 0 R
>>
/ProcSet [/PDF /Text /ImageB]
/ExtGState <<
/GS0 48 0 R
/GS1 49 0 R
/GS2 50 0 R
/GS3 51 0 R
>>
>>
/Type /Page
>>
endobj
13 0 obj
<<
/St 1681
/S /D
>>
endobj
14 0 obj
<<
/Length 2598
/Filter /FlateDecode
/N 3
>>
stream
hޜwTTϽwz0z.0. Qf Ml@DEHb!(`HPb0dFJ|yyǽgs{. $O./ 'z8WGб x 0Y驾A@$/7z HeOOҬT _lN:K"N3"$F/JPrb[䥟}Qd[Sl1x{#bG\NoX3I[ql2 $8xtr p/8pCfq.Knjm͠{r28?.)ɩL^6 g,qm"[Z[Z~Q7%"
3R `̊j[~ : w! $E}kyhyRm333:
}=#vʉe
tqX)I)B>==
<8Xȉ9